| Data set | Procedure | What's in this data set | Panel | Sex | Age (weeks) | Year |
|---|---|---|---|---|---|---|
|
|
biomarker quantification
with high-fat high-sucrose diet |
Bile acids in feces. | DO population | both | 4-26wks | 2018 |
|
|
body weight
with high-fat high-sucrose diet |
Weekly. | DO population | both | 4-26wks | 2018 |
|
|
colony observation
with high-fat high-sucrose diet |
Number of days on high-fat high-sucrose diet. | DO population | both | 4-26wks | 2018 |
|
|
DXA
with high-fat high-sucrose diet |
Bone mineral density. Isolated tibia. | DO population | both | 4-26wks | 2018 |
|
|
glucose tolerance
with high-fat high-sucrose diet |
Area under curve. | DO population | both | 4-26wks | 2018 |
|
|
hormone quantification
with high-fat high-sucrose diet |
Plasma insulin, adiponectin, leptin. Ex vivo insulin secretion. | DO population | both | 4-26wks | 2018 |
|
|
intake monitoring
with high-fat high-sucrose diet |
Food intake. Weekly. | DO population | both | 4-26wks | 2018 |
|
|
lipid profile
with high-fat high-sucrose diet |
Triglyceride. | DO population | both | 4-26wks | 2018 |
|
|
metabolic panel
with high-fat high-sucrose diet |
Glucose, HOMA-IR, HOMA-B. | DO population | both | 4-26wks | 2018 |
|
|
microscopy
with high-fat high-sucrose diet |
Number of islets harvested. | DO population | both | 4-26wks | 2018 |
|
|
organ weights
with high-fat high-sucrose diet |
Heart, liver, gonadal fat pads. | DO population | both | 4-26wks | 2018 |
|
|
glucose tolerance
with high-fat diet |
High-fat diet vs. control. 0 to 120 min after 20% glucose i.p. 18h fast. | DO population | both | 8,19wks | 2015 |
|
|
lipid profile
with high-fat diet |
Cholesterol, HDL, triglycerides, fatty acids. High-fat diet vs. control. Two age cohorts. 4h fast, plasma. | DO population | both | 8,19wks | 2015 |
|
|
metabolic panel
with high-fat diet |
Clinical blood chemistry (plasma). High-fat diet vs. control. Some parameters at two age timepoints. 4h fast or no fast. | DO population | both | 8,19wks | 2015 |
|
|
complete blood count
with high-fat diet |
Hematology. High-fat diet vs. control. Two age cohorts. | DO population | both | 10,22wks | 2015 |
|
|
body weight
with high-fat diet |
Body weight and growth curve from age 3wks to 22wks weighed weekly. High-fat diet vs. control. | DO population | both | 3-32wks | 2015 |
|
|
organ weights
with high-fat diet |
Heart, kidney, spleen weights. High-fat diet vs. control. | DO population | both | 3-32wks | 2015 |
|
|
body size and weight
with high-fat diet |
Body weight and length. High-fat diet vs. control. Two age cohorts. | DO population | both | 11-22wks | 2015 |
|
|
DXA
with high-fat diet |
Body mass, fat mass, lean mass, bone mineral density and content, bone area. High-fat diet vs. control. Two age cohorts. | DO population | both | 11-22wks | 2015 |
|
|
ECG
with high-fat diet |
Wave amplitudes and intervals. Conscious. High-fat diet vs. control. Two age cohorts. | DO population | both | 11-22wks | 2015 |
|
|
urinalysis
with high-fat diet |
Glucose, creatinine, albumin. High-fat diet vs. control. Two age cohorts. | DO population | both | 11-22wks | 2015 |
|
|
body weight | Body weight | DO population w/par (9) | both | 12-16wks | 2013 |
|
|
light-dark box | Anxiety, avoidance behavior. 20 min test. | DO population w/par (9) | both | 12-16wks | 2013 |
|
|
nociception assay | Hot plate. | DO population w/par (9) | both | 12-16wks | 2013 |
|
|
open field test | Locomotor activity, exploratory, anxiety-related behavior. 20 min test. | DO population w/par (9) | both | 12-16wks | 2013 |
|
|
tail suspension test | Frequency climbing, time immobile, latency immobile. 5 min test. | DO population w/par (9) | both | 12-16wks | 2013 |
|
|
visual cliff | Anxiety, avoidance behavior. 20 min test. | DO population w/par (9) | both | 12-16wks | 2013 |
|
|
hole board test
with cocaine |
Exploratory behavior. 10 min test. | DO population | both | 12-16wks | 2015 |
|
|
monitoring system
with cocaine |
Novelty preference test (preference for novel side vs. familiar side). 10 min test. | DO population | both | 12-16wks | 2015 |
|
|
open field test
with cocaine |
Locomotor activity and exploratory behavior. 20 min test. | DO population | both | 12-16wks | 2015 |
|
|
operant conditioning chamber
with cocaine |
Intravenous self-administration of cocaine via activation of levers. | DO population | both | 12-16wks | 2015 |
|
|
chromosome instability assessment
with benzene |
Percentages of erythrocytes and reticulocytes that are micronucleated before and after exposure. | DO population | m | 5-8wks | 2015 |
|
|
study archive | Whole blood neutrophil count and white cell count. | DO population | both | 10-12wks | 2014 |
|
|
body weight | Body weight | DO population | both | 8-60 wks | 2020 |
|
|
bone dimensions | 3D, craniofacial landmark coordinates based on centroid. | DO population | both | 8-60 wks | 2020 |
|
|
study archive | Hot plate nociception. | DO population | both | 13-17wks | 2013 |
|
|
nociception assay | Formalin injection. | DO population | both | 13-17wks | 2019 |
|
|
body weight
with various diets |
Diets vs controls. | DO population | both | 12-15wks, 24-25wks | 2018 |
|
|
bone dimensions
with various diets |
Femur length. Diets vs controls. | DO population | both | 12-15wks, 24-25wks | 2018 |
|
|
colony observation
with various diets |
Diets vs controls. | DO population | both | 12-15wks, 24-25wks | 2018 |
|
|
organ weights
with various diets |
Heart weight, raw, adjusted to body weight, adjusted to femur length. Diets vs controls. | DO population | both | 12-15wks, 24-25wks | 2018 |
|
|
body weight | Body weight | DO population | m | 12-15wks | 2020 |
|
|
histopathology | Male reproductive histopathology. Percent normal, abnormal sperm. | DO population | m | 12-15wks | 2020 |
|
|
microscopy | Sperm motility | DO population | m | 12-15wks | 2020 |
|
|
organ weights | Male reproductive organ weights. Testes, seminal vesicles, epididymis + vas deferens. | DO population | m | 12-15wks | 2020 |
|
|
sperm count | Sperm count. Hemocytometer. | DO population | m | 12-15wks | 2020 |
|
|
body size and weight
with high-fat high-sucrose diet |
Body length at 12 and 21 wks of age. | DO population | both | 3-30 wks | 2020 |
|
|
body weight
with high-fat high-sucrose diet |
Body weight from 3-30 wks of age. Principal components. | DO population | both | 3-30 wks | 2020 |
|
|
complete blood count
with high-fat high-sucrose diet |
Hematology at 10 and 22 wks of age. | DO population | both | 3-30 wks | 2020 |
|
|
DXA
with high-fat high-sucrose diet |
Body mass, lean mass, fat mass, bone mineral density at 12 and 21 wks of age. | DO population | both | 3-30 wks | 2020 |
|
|
ECG
with high-fat high-sucrose diet |
Heart rate and wave intervals at 13 wks. Conscious. | DO population | both | 3-30 wks | 2020 |
|
|
glucose tolerance
with high-fat high-sucrose diet |
0-180 min after 20% glucose i.p. at 23-24 wks of age. 15h fast. | DO population | both | 3-30 wks | 2020 |
|
|
lipid profile
with high-fat high-sucrose diet |
Cholesterol, fatty acids, triglyceride at 8 and 19 wks of age. 4h fast. | DO population | both | 3-30 wks | 2020 |
|
|
metabolic panel
with high-fat high-sucrose diet |
Clinical chemistry at 8 and 19 wks of age. 4h fast. Clinical chemistry at 17 wks of age. No fast. | DO population | both | 3-30 wks | 2020 |
|
|
MRI
with high-fat high-sucrose diet |
Lean and fat tissue mass, water mass at 16 wks of age. | DO population | both | 3-30 wks | 2020 |
|
|
organ weights
with high-fat high-sucrose diet |
Heart, kidney, spleen at 26-30 wks. | DO population | both | 3-30 wks | 2020 |
|
|
urinalysis
with high-fat high-sucrose diet |
Glucose, creatinine, microalbumin, albumin-creatinine ratio at 11 and 20 wks of age. | DO population | both | 3-30 wks | 2020 |
|
|
body weight
with arsenic |
Baseline, then after iAs exposure for 26 wks | DO population | m | 4-34 wks | 2022 |
|
|
hormone quantification
with arsenic |
Blood insulin following 6 h fast, and after intraperitoneal glucose injection; at baseline and after iAs exposure | DO population | m | 4-34 wks | 2022 |
|
|
intake monitoring
with arsenic |
Food and water consumption, at baseline then at 1 to 4 wk intervals after iAs exposure | DO population | m | 4-34 wks | 2022 |
|
|
metabolic panel
with arsenic |
Blood glucose following 6 h fast, and after intraperitoneal glucose injection; at baseline and after iAs exposure | DO population | m | 4-34 wks | 2022 |
|
|
metabolite quantification
with arsenic |
iAs quantification in urine and liver, at 24 and 26 wks after iAs exposure. IAs speciation evaluated specifically monomethyl-arsenic acid (MMA) and dimethyl-arsenic acid (DMA) | DO population | m | 4-34 wks | 2022 |
|
|
MRI
with arsenic |
Fat and lean tissue mass at baseline, and 12 and 24 wks after iAs exposure | DO population | m | 4-34 wks | 2022 |
|
|
urinalysis
with arsenic |
Urine volume at baseline, and 12 and 24 wks after iAs exposure | DO population | m | 4-34 wks | 2022 |